Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Comprehensive Summary of the Knowledge on COVID-19 Treatment
Yu Peng, Hongxun Tao, Senthil Kumaran Satyanarayanan, et al.
Aging and Disease (2021) Vol. 12, Iss. 1, pp. 155-155
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Rutin Is a Low Micromolar Inhibitor of SARS-CoV-2 Main Protease 3CLpro: Implications for Drug Design of Quercetin Analogs
Bruno Rizzuti, Fedora Grande, Filomena Conforti, et al.
Biomedicines (2021) Vol. 9, Iss. 4, pp. 375-375
Open Access | Times Cited: 74
Lockdown Due to COVID-19 and Its Consequences on Diet, Physical Activity, Lifestyle, and Other Aspects of Daily Life Worldwide: A Narrative Review
Teresa Rubio‐Tomás, Maria Skouroliakou, Dimitrios Ntountaniotis
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 11, pp. 6832-6832
Open Access | Times Cited: 37
Persistent Lung Injury and Prothrombotic State in Long COVID
Mengqi Xiang, Haijiao Jing, Chengyue Wang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 30
Drug-induced liver injury and COVID-19: A review for clinical practice
Gabriela Xavier Ortiz, Gabriele Lenhart, Matheus William Becker, et al.
World Journal of Hepatology (2021) Vol. 13, Iss. 9, pp. 1143-1153
Open Access | Times Cited: 31
Effect of the number of coronavirus disease 2019 (COVID-19) vaccination shots on the occurrence of pneumonia, severe pneumonia, and death in SARS-CoV-2-infected patients
Shijun Xin, Wei Chen, Qilin Yu, et al.
Frontiers in Public Health (2024) Vol. 11
Open Access | Times Cited: 4
COVID-19: Has the Liver Been Spared?
Nicolò Brandi, Daniele Spinelli, Alessandro Granito, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1091-1091
Open Access | Times Cited: 10
Nanomaterials in Medicine: Understanding Cellular Uptake, Localization, and Retention for Enhanced Disease Diagnosis and Therapy
Yue Peng, Zhengshuang Yang, Hui‐Chuan Sun, et al.
Aging and Disease (2024)
Open Access | Times Cited: 3
Traditional Chinese Medicine and Western Medicine Share Similar Philosophical Approaches to Fight COVID-19
Fangfang Zhao, Zhenhong Yang, Ningqun Wang, et al.
Aging and Disease (2021) Vol. 12, Iss. 5, pp. 1162-1162
Open Access | Times Cited: 23
Efficacy and safety of current medications for treating severe and non-severe COVID-19 patients: an updated network meta-analysis of randomized placebo-controlled trials
Qinglin Cheng, Chen Jun-fang, Qingjun Jia, et al.
Aging (2021) Vol. 13, Iss. 18, pp. 21866-21902
Open Access | Times Cited: 22
Evaluation of the Pharmacologic Treatment of COVID-19 Pandemic in Iraq
Omeed Darweesh, Ghayth Abdulrazzaq, Radhwan Nidal Al-Zidan, et al.
Current Pharmacology Reports (2021) Vol. 7, Iss. 4, pp. 171-178
Open Access | Times Cited: 21
The Pathogenetic Dilemma of Post-COVID-19 Mucormycosis in India
Sankha Shubhra Chakrabarti, Upinder Kaur, Sushil Kumar Aggarwal, et al.
Aging and Disease (2022) Vol. 13, Iss. 1, pp. 24-24
Open Access | Times Cited: 11
COVID-19 drug-induced liver injury: A recent update of the literature
Lekha Saha, Soumya Vij, Kajal Rawat
World Journal of Gastroenterology (2022) Vol. 28, Iss. 45, pp. 6314-6327
Open Access | Times Cited: 11
Shortening the long-COVID: An exploratory review on the potential of Unani medicines in mitigating post-Covid-19 sequelae
Sadia Nikhat, Mohammad Fazil
Phytomedicine Plus (2024) Vol. 4, Iss. 2, pp. 100570-100570
Open Access | Times Cited: 2
A Large-Scale Dataset of Twitter Chatter about Online Learning during the Current COVID-19 Omicron Wave
Nirmalya Thakur
Data (2022) Vol. 7, Iss. 8, pp. 109-109
Open Access | Times Cited: 10
Medicinal Plants and Zinc: Impact on COVID-19 Pandemic
Zineb Jalal, Meryem Bakour, Badiâa Lyoussi
The Scientific World JOURNAL (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 13
A Large-Scale Dataset of Twitter Chatter about Online Learning during the Current COVID-19 Omicron Wave
Nirmalya Thakur
(2022)
Open Access | Times Cited: 9
Attitudes and beliefs regarding the use of herbs and supplementary medications with COVID-19: A systematic review
Abderrezzaq Soltani, Myriam Jaam, Zachariah Nazar, et al.
Research in Social and Administrative Pharmacy (2022) Vol. 19, Iss. 3, pp. 343-355
Open Access | Times Cited: 8
A Large-Scale Dataset of Twitter Chatter about Online Learning during the Current COVID-19 Omicron Wave
Nirmalya Thakur
(2022)
Open Access | Times Cited: 7
Further validation of the efficacy of mesenchymal stem cell infusions for reducing mortality in COVID-19 patients with ARDS
Ashok K. Shetty, Padmashri A Shetty, Gabriele Zanirati, et al.
npj Regenerative Medicine (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 6
Are Host Defense Peptides and Their Derivatives Ready to be Part of the Treatment of the Next Coronavirus Pandemic?
Bruno Rivas‐Santiago, Yolanda M. Jacobo-Delgado, Adrián Rodríguez-Carlos
Archivum Immunologiae et Therapiae Experimentalis (2021) Vol. 69, Iss. 1
Open Access | Times Cited: 6
CAN BAICALEIN BECOME A NEW DRUG FOR COVID-19?
Jiří Patočka, Zdeňka Navrátilová, Kamil Kuča, et al.
Military Medical Science Letters (2021) Vol. 90, Iss. 4, pp. 198-207
Open Access | Times Cited: 4
Healthcare professionals’ understanding and perception of drug-related issues linked to off-label pharmacological medications used for COVID-19
Muhammad Zeeshan Munir, Amer Hayat Khan, Tahir Mehmood Khan
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 6, pp. 487-493
Closed Access
Pemberdayaan Masyarakat dalam Penanggulangan COVID-19 pada Lansia dengan Komorbid Sindroma Metabolik di Sukoharjo Jawa Tengah
Sri Suwarni
Madaniya (2024) Vol. 5, Iss. 1, pp. 1-11
Open Access
The Impact of COVID-19 Pandemic on Patients' Attitudes Towards Traditional and Complementary Medicine: A Cross-Sectional Study
Bilal KARABAŞ, Ersan Gürsoy
Journal of Traditional Medical Complementary Therapies (2024) Vol. 7, Iss. 1, pp. 8-15
Open Access
Efficacy and Safety of CVO PLUS CURATIF Capsules, Malagasy Improved Traditional Medication for Treating COVID-19: A Randomized, Double- Blind, Placebo-Controlled Trial
Rianasoambolanoro Rakotosaona, Sedera A. Mioramalal
Archives of Clinical and Biomedical Research (2022) Vol. 06, Iss. 05
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top